|
YAP1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.94240001860635E-09 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.27389995511152E-09 |
| Normal-vs-Stage2 |
3.57410000000336E-05 |
| Normal-vs-Stage3 |
3.77179999999644E-06 |
| Normal-vs-Stage4 |
1.90455999999894E-05 |
| Stage1-vs-Stage2 |
9.582400E-01 |
| Stage1-vs-Stage3 |
9.220000E-01 |
| Stage1-vs-Stage4 |
5.622000E-01 |
| Stage2-vs-Stage3 |
9.738800E-01 |
| Stage2-vs-Stage4 |
6.795600E-01 |
| Stage3-vs-Stage4 |
6.471000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.27720001241727E-09 |
| Normal-vs-AfricanAmerican |
8.37249999996459E-07 |
| Normal-vs-Asian |
9.380800E-04 |
| Caucasian-vs-AfricanAmerican |
4.355000E-01 |
| Caucasian-vs-Asian |
7.946000E-01 |
| AfricanAmerican-vs-Asian |
5.940600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.63602464908763E-12 |
| Normal-vs-Female |
8.962000E-03 |
| Male-vs-Female |
9.96030000000037E-05 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.87310000019114E-07 |
| Normal-vs-Extreme_Weight |
1.72620029381676E-10 |
| Normal-vs-Obese |
1.96738000000085E-05 |
| Normal-vs-Extreme_Obese |
3.03169999993358E-07 |
| Normal_Weight-vs-Extreme_Weight |
4.031800E-01 |
| Normal_Weight-vs-Obese |
2.697600E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.461000E-01 |
| Extreme_Weight-vs-Obese |
2.656200E-02 |
| Extreme_Weight-vs-Extreme_Obese |
4.695800E-01 |
| Obese-vs-Extreme_Obese |
7.261800E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.397800E-02 |
| Normal-vs-Age(41-60Yrs) |
4.60109999989022E-07 |
| Normal-vs-Age(61-80Yrs) |
8.67500515866482E-11 |
| Normal-vs-Age(81-100Yrs) |
1.78830000030494E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.885000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.212020E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.651900E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.032210E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.070100E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.255200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.74060013466726E-10 |
| Normal-VS-Type2 PRCC |
7.12390146873076E-11 |
| Normal-VS-KIRP CIMP |
6.099200E-01 |
| Normal-VS-Unclassified PRCC |
4.415200E-04 |
| Type1 PRCC-VS-Type2 PRCC |
6.547000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.700150E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
1.571820E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.821900E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
1.514380E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
8.761900E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.18699494677799E-11 |
| Normal-vs-N1 |
3.759100E-04 |
| Normal-vs-N2 |
5.081800E-03 |
| N0-vs-N1 |
3.842300E-02 |
| N0-vs-N2 |
7.004600E-01 |
| N1-vs-N2 |
5.738600E-01 |
|
|
